The Trade-offs When Focusing on the Mortality Benefit
Abstract
Opinion EDITORIAL Albert Liu, MD; Gregory Curfman, MD There is growing evidence that patients have varying priori- decision making is that clinicians are transparent with their rec- ties at the end of their life. Some want to focus on maximiz- ommendations—and their implications, both positive and nega- ing their quality of life, whereas others focus on living longer. tive. When survival benefit is overemphasized and risks are underestimated, patients risk deciding on therapies that are...